» Articles » PMID: 22551767

Wild-type Coxsackievirus Infection Dramatically Alters the Abundance, Heterogeneity, and Immunostimulatory Capacity of Conventional Dendritic Cells in Vivo

Overview
Journal Virology
Specialty Microbiology
Date 2012 May 4
PMID 22551767
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro studies have shown that enteroviruses employ strategies that may impair the ability of DCs to trigger T cell immunity, but it is unclear how these viruses affect DCs in vivo. Here, we evaluate the effects of wild-type (wt) coxsackievirus B3 on DCs in vitro and in a murine model in vivo. Although CVB3 does not productively infect the vast majority of DCs, virus infection profoundly reduces splenic conventional DC numbers and diminishes their capacity to prime naïve CD8(+) T cells in vitro. In contrast to recombinant CVB3, highly pathogenic wt virus infection significantly diminishes the host's capacity to mount T cell responses, which is temporally associated with the loss of CD8α(+) DCs. Our findings demonstrate that enterovirus infection substantially alters the number, heterogeneity, and stimulatory capacity of DCs in vivo, and these dramatic immunomodulatory effects may weaken the host's capacity to mount antiviral T cell responses.

Citing Articles

Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus.

Fukui T, Kobayashi T, Jimbo E, Aida K, Shimada A, Oikawa Y Sci Rep. 2023; 13(1):6977.

PMID: 37117225 PMC: 10147722. DOI: 10.1038/s41598-023-33011-7.


Coxsackievirus B3-Its Potential as an Oncolytic Virus.

Geisler A, Hazini A, Heimann L, Kurreck J, Fechner H Viruses. 2021; 13(5).

PMID: 33919076 PMC: 8143167. DOI: 10.3390/v13050718.


Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives.

Wei Y, Wang H, Xi C, Li N, Li D, Yao C Molecules. 2020; 25(6).

PMID: 32204528 PMC: 7144376. DOI: 10.3390/molecules25061409.


Enterovirus infection and type 1 diabetes: unraveling the crime scene.

Rodriguez-Calvo T Clin Exp Immunol. 2018; 195(1):15-24.

PMID: 30307605 PMC: 6300647. DOI: 10.1111/cei.13223.


In silico and ex vivo approaches indicate immune pressure on capsid and non-capsid regions of coxsackie B viruses in the human system.

Kundu R, Knight R, Dunga M, Peakman M PLoS One. 2018; 13(6):e0199323.

PMID: 29924875 PMC: 6010236. DOI: 10.1371/journal.pone.0199323.


References
1.
Villadangos J, Young L . Antigen-presentation properties of plasmacytoid dendritic cells. Immunity. 2008; 29(3):352-61. DOI: 10.1016/j.immuni.2008.09.002. View

2.
Kemball C, Harkins S, Whitmire J, Flynn C, Feuer R, Whitton J . Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PLoS Pathog. 2009; 5(10):e1000618. PMC: 2757675. DOI: 10.1371/journal.ppat.1000618. View

3.
Schulte B, Kramer M, Ansems M, Lanke K, van Doremalen N, Piganelli J . Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells. Diabetes. 2010; 59(5):1182-91. PMC: 2857898. DOI: 10.2337/db09-1071. View

4.
Dietz Jr W, Peralta P, Johnson K . Ten clinical cases of human infection with venezuelan equine encephalomyelitis virus, subtype I-D. Am J Trop Med Hyg. 1979; 28(2):329-34. DOI: 10.4269/ajtmh.1979.28.329. View

5.
Romero J . Pediatric group B coxsackievirus infections. Curr Top Microbiol Immunol. 2008; 323:223-39. DOI: 10.1007/978-3-540-75546-3_10. View